Sullivan Christopher Ryan bought AVTX
March 28, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 24,200 shares of Avalo Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,200
Price
N/A
Total value
N/A
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 28, 2026
Filing dateMarch 31, 2026
Shares owned after41,538
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.